Retinal vascular signs as screening and prognostic factors for chronic kidney disease: a systematic review and meta-analysis of current evidence

Published

2021

Audience

Therapeutic Area

Content Type

AI Generated Summary*

Retinal microvascular signs were examined as markers of prevalent and incident chronic kidney disease in a pooled review of 42 eligible reports, mostly cross-sectional (32), alongside nine prospective cohorts and one retrospective study, identified through PubMed, Embase and cross-referencing. Quality scoring rated 22 at low, 11 at moderate and 9 at high risk of bias, and only six reports entered four pooled analyses. Retinopathy tracked with end-stage renal disease (HR 2.12, 95% CI 1.39 to 3.22) and with prevalent CKD generally (OR 1.31, 1.14 to 1.50) and in type 2 diabetes (OR 1.68, with notable heterogeneity); narrower arteriolar caliber accompanied prevalent CKD (OR 1.41, 1.09 to 1.82). Prospective caliber results were mixed, so the suggested screening role stays provisional.

*This summary was generated by AI and is published unedited. Oku does not alter these summaries. It may contain errors or omissions and is provided for general informational purposes only. Oku does not guarantee its accuracy, completeness, or reliability. For authoritative information, please refer to the original, peer-reviewed article.

At a glance

Authors
Michael Aronov; Raviv Allon; Danielle Stave; Michael Belkin; Eyal Margalit; Ido Didi Fabian; Barak Rosenzweig
Publication
Journal of Personalized Medicine
Keywords
Chronic Kidney Disease, Diabetic Retinopathy, End-Stage Renal Disease, Fundus Photography, Glomerular Filtration Rate, Retinal Vascular Diameter
Year
2021
View primary source

This is the evidence

See where we take it next

Join the Network